Impact of Blood Phobia on Fainting Susceptibility
Simon Fraser University
20 participants
Mar 30, 2024
INTERVENTIONAL
Conditions
Summary
The primary purpose of this study is to characterize cardiovascular autonomic function to emotional stimuli (blood-injection-injury phobia \[needle phobia\]) during an orthostatic (upright) challenge in individuals with and without known needle phobia. It is well established that emotional stress can produce hypotensive (low blood pressure) reactions. Interestingly, these hypotensive reactions to venipuncture (even with minimal blood drawn), insulin injections, finger sticks for blood sugar monitoring, dental care, and vaccinations can affect up to a quarter of adults and appear to be uniquely associated with blood-injection-injury phobia rather than other phobias. These hypotensive reactions can ultimately lead to a vasovagal syncope (fainting) response, and lead to increased avoidance of medical and dental procedures as a result of this phobia. Ultimately, this has severe implications on public health and places additional strain on the Canadian healthcare system. Currently, there is limited understanding surrounding the initiation of this response. Additionally, a comprehensive profile of cardiovascular autonomic function during exposure to provoking stimuli during orthostatic stress has not been captured in the literature. We will test individuals with and without blood-injection-injury phobia using our standard approach while exposing them to emotional stimuli.
Eligibility
Inclusion Criteria4
- male and female
- to 50 years old
- those without a suspected BII fear and those with a suspected fear
- english speaking
Exclusion Criteria4
- diagnosis of any cardiovacular or neurological disorder
- menopausal
- taking medication for a cardiovascular condition
- if they are pregnant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
498 seconds of BII phobia-related images and videos will begin two-minutes prior to head-up tilt test, while in supine.
498 seconds of neutral images and videos will begin two-minutes prior to head-up tilt test, while in supine.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06336031